Cisen Pharmaceutical Co.,Ltd.’s Net Profit Rose 37.9% in First Three Quarters of 2023

Cisen Pharmaceutical Co.,Ltd. (辰欣药业股份有限公司) (603367.SH) reported a net profit of 395.6 million yuan in the first three quarters of 2023, up 37.9% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 7.1 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 20.7%.